E-Cigarettes vs. medication: a new hope for stubborn smokers?

NCT ID NCT06373679

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This study compares e-cigarettes to FDA-approved medications (nicotine replacement therapy or varenicline) for helping smokers who have previously failed to quit. Participants are randomly assigned to one of two groups and can choose their preferred product within that group. The goal is to see if switching to e-cigarettes leads to more successful quitting than traditional methods.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
e-cigarette, varenicline, nicotine replacement therapy
What this could lead to
If successful, this could offer a harm reduction option for smokers who have not been able to quit with standard treatments.
What could go wrong
The trial is relatively small and early-stage, and e-cigarettes carry their own health risks. Success depends on complete switching and long-term abstinence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIGARETTE SMOKING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cigarette Smoking Smoking

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Medical Univeristy of South Carolina

    RECRUITING

    Charleston, South Carolina, 29425, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.